ArticleChest2021

Molecular Biomarker and Programmed Death-Ligand 1 Expression Testing in Patients With Advanced Stage Non-small Cell Lung Cancer Across North Carolina Community Hospitals.

M Patricia Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.